These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20019770)

  • 21. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
    Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Avidity of anti-glomerular basement membrane autoantibodies was associated with renal pathological damage].
    Cui Z; Zhao MH
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):903-7. PubMed ID: 16029529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity.
    Cui Z; Zhao MH
    Clin Immunol; 2005 Jul; 116(1):77-82. PubMed ID: 15925834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.
    Li JN; Cui Z; Wang J; Hu SY; Jia XY; Guan Z; Chen M; Xie C; Zhao MH
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):568-75. PubMed ID: 26813562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis.
    de Joode AA; Roozendaal C; van der Leij MJ; Bungener LB; Sanders JS; Stegeman CA
    Eur J Intern Med; 2014 Feb; 25(2):182-6. PubMed ID: 24361117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort.
    Shen CR; Jia XY; Cui Z; Yu XJ; Zhao MH
    Front Immunol; 2020; 11():2035. PubMed ID: 33013861
    [No Abstract]   [Full Text] [Related]  

  • 27. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glomerular C1q deposition and serum anti-C1q antibodies in anti-glomerular basement membrane disease.
    Hu SY; Jia XY; Yang XW; Yu F; Cui Z; Zhao MH
    BMC Immunol; 2013 Sep; 14():42. PubMed ID: 24053688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 25-year experience with pediatric anti-glomerular basement membrane disease.
    Williamson SR; Phillips CL; Andreoli SP; Nailescu C
    Pediatr Nephrol; 2011 Jan; 26(1):85-91. PubMed ID: 20963446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules.
    Chen M; Zhao MH; Zhang YK; Wang HY
    Nephrology (Carlton); 2005 Oct; 10(5):491-5. PubMed ID: 16221101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury.
    Jia XY; Cui Z; Yang R; Hu SY; Zhao MH
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):926-33. PubMed ID: 22461538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and features of dual anti-GBM-positive and ANCA-positive patients.
    DE Zoysa J; Taylor D; Thein H; Yehia M
    Nephrology (Carlton); 2011 Nov; 16(8):725-9. PubMed ID: 21649794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and Outcomes of Patients with Anti-Glomerular Basement Membrane Antibody Disease and Anti-Neutrophil Cytoplasmic Antibodies.
    Balderia PG; Andeen N; Jefferson JA
    Curr Rheumatol Rev; 2019; 15(3):224-228. PubMed ID: 29766817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort.
    Alchi B; Griffiths M; Sivalingam M; Jayne D; Farrington K
    Nephrol Dial Transplant; 2015 May; 30(5):814-21. PubMed ID: 25609740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-GBM antibodies co-exist with MPO-ANCA in a 4-year-old girl with acute renal failure.
    Naidoo S; Waller S
    Pediatr Nephrol; 2009 Jan; 24(1):215-6. PubMed ID: 18607637
    [No Abstract]   [Full Text] [Related]  

  • 36. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
    Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease.
    Yang R; Cui Z; Zhao J; Zhao MH
    Clin Immunol; 2009 Nov; 133(2):245-50. PubMed ID: 19654074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study.
    Mahler M; Radice A; Sinico RA; Damoiseaux J; Seaman A; Buckmelter K; Vizjak A; Buchner C; Binder WL; Fritzler MJ; Cui Z
    Nephrol Dial Transplant; 2012 Jan; 27(1):243-52. PubMed ID: 21562146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the performance of a chemiluminescence assay and an ELISA for detection of anti-GBM antibodies.
    Tan Y; Pang W; Jia X; Zhao MH
    Ren Fail; 2020 Nov; 42(1):48-53. PubMed ID: 31885301
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical consequence and significance of anti-neutrophil cytoplasmic antibody positivity in anti-glomerular basement membrane disease].
    File I; Pucsok K; Trinn C; Ujhelyi L; Balla J; Mátyus J
    Orv Hetil; 2013 Oct; 154(43):1696-701. PubMed ID: 24140508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.